Avenue Therapeutics, Inc(NASDAQ:ATXI) 
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderatel...
Website: http://www.avenuetx.com
Founded: 2015
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.25
H 0.29
L 0.25
C 0.26
V 16,341
10EMA 0.26
20EMA 0.26
60EMA 0.26
120EMA 0.26
250EMA 0.26